SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma
Clinical trial NCT01574274 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01574274
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2021-07-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.